英国 6250 万人研究:406 种罕见病患病率与 COVID-19 感染率随族裔而异
Prevalence of 406 rare diseases by ethnicity and recorded COVID-19 infection rates among 62.5 million people in England
英国一项覆盖 6250 万人的研究显示,约 105 万人(1.7%)患有 406 种罕见病中的至少一种。罕见病群体记录的 COVID-19 感染率为 32.8%,高于非罕见病群体的 29.0%,且各族裔间存在差异。按更细的族裔分类分析时,罕见病患病率差异显著,宽泛分类可能掩盖这些差异。
- Article
- Open access
- Published: 18 October 2026
- Qingze Gu1,
- Seyed Alireza Hasheminasab1,
- Marta Pineda-Moncusí1,
- Chimweta Chilala2,
- Johan H. Thygesen3,
- Honghan Wu3,
- Sara Khalid1 &
- CVD-COVID-UK/COVID-IMPACT Consortium
Scientific Reports (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
Rare diseases (RD) are individually uncommon but collectively affect millions of people. Yet national estimates of their prevalence, especially across ethnic groups, are limited, and how the COVID-19 pandemic affected people with RD across ethnic groups is unknown. We aimed to estimate the prevalence of 406 RD by ethnicity, and to describe recorded COVID-19 infection across these RD and ethnic groups, in England. We conducted a cross-sectional study within the National Health Service (NHS) England Secure Data Environment, accessed via the British Heart Foundation (BHF) Data Science Centre’s CVD-COVID-UK/COVID-IMPACT Consortium, linking primary care, hospital, and mortality records for individuals alive on 31 July 2023. We calculated age- and sex-standardised prevalence for 406 RD, and recorded COVID-19 infection rates for the overall group, for each RD, and across the six-group Office for National Statistics (ONS) and 19-group NHS ethnicity classifications. Of 62.5 million people, 1.05 million (1.7%) had at least one of the 406 RD. Recorded COVID-19 infection was higher in the RD group than in the non-RD population (32.8% vs. 29.0%). Within the RD group, infection rates varied by ethnicity (e.g. 27.7% in the Pakistani and 23.8% in the Black African groups, versus 33.7% in the White British group) and by specific RD (24.6–41.2% among the 25 most common). Age- and sex-standardised prevalence also varied widely across ethnic groups, with substantial heterogeneity emerging only when broad categories were disaggregated into the more granular NHS classifications (for example, markedly elevated discoid lupus erythematosus prevalence in Black Caribbean but not Black African individuals, obscured within the aggregate “Black” category). This national, ethnicity-resolved map shows that rare-disease prevalence varies substantially across ethnic groups, with differences largely hidden within broad categories, and that recorded COVID-19 infection among people with RD varied across ethnic groups, with the highest rates observed in the ONS White and NHS White British groups. These findings provide a baseline to support earlier, fairer diagnosis and more targeted care.
Abbreviations
- BHF:
-
British Heart Foundation
- CHESS:
-
COVID-19 Hospitalisations in England surveillance system
- CI:
-
Confidence interval
- CVD:
-
Cardiovascular disease
- EHR:
-
Electronic health record
- GDPPR:
-
General practice extraction service data for pandemic planning and research
- GPES:
-
General practice extraction service
- HES-APC:
-
Hospital episode statistics admitted patient care
- HES-OPC:
-
Hospital episode statistics outpatient care
- ICD-10:
-
International classification of diseases, tenth revision
- IMD:
-
Index of multiple deprivation
- LFD:
-
Lateral flow device
- NHS:
-
National Health Service
- ONS:
-
Office for national statistics
- OR:
-
Odds ratio
- PCR:
-
Polymerase chain reaction
- RD:
-
Rare disease
- SDE:
-
Secure data environment
- SGSS:
-
Second generation surveillance system
- SNOMED CT:
-
Systematised nomenclature of medicine clinical terms
Acknowledgements
This work was carried out with the support of the BHF Data Science Centre led by Health Data Research UK (BHF Grant no. SP/19/3/34678). This study made use of anonymised data held in NHS England’s Secure Data Environment service for England and made available via the BHF Data Science Centre’s CVD-COVID-UK/COVID-IMPACT consortium. This work used data provided by patients and collected by the NHS as part of their care and support. We would also like to acknowledge all data providers who make health relevant data available for research. The BHF Data Science Centre’s Health Data Science Team provided data curation resources and support. We also thank Huayu Zhang for his contributions to the foundational phenotyping workflows. This research is part of the Data and Connectivity National Core Study, led by Health Data Research UK in partnership with the Office for National Statistics and funded by UK Research and Innovation (grant ref MC_PC_20058). The Alan Turing Institute also supported this work via ‘Towards Turing 2.0’ EPSRC Grant Funding. The funders had no role in the study design, data collection, data analysis, data interpretation, or report writing.
Funding
The British Heart Foundation Data Science Centre (grant No SP/19/3/34678, awarded to Health Data Research (HDR) UK), funded co-development (with NHS England) of the Secure Data Environment service for England, provision of linked datasets, data access, user software licences, computational usage, data management and wrangling support, and part-funded the time of contributing data analysts, biostatisticians, epidemiologists, and clinicians, to coordinate national COVID-19 priority research.
Author information
Author notes
A list of authors and their affiliations appears at the end of the paper.
Authors and Affiliations
Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK
Qingze Gu, Seyed Alireza Hasheminasab, Marta Pineda-Moncusí & Sara Khalid
Cardiovascular Epidemiology Unit, University of Cambridge, Cambridge, UK
Chimweta Chilala
Institute of Health Informatics, University College London, London, UK
Johan H. Thygesen & Honghan Wu
British Heart Foundation Data Science Centre, Health Data Research UK, London, UK
Amy Coombe
Authors
- Qingze Gu
- Seyed Alireza Hasheminasab
- Marta Pineda-Moncusí
- Chimweta Chilala
- Johan H. Thygesen
- Honghan Wu
- Sara Khalid
Consortia
CVD-COVID-UK/COVID-IMPACT Consortium
- Amy Coombe
Corresponding author
Correspondence to Sara Khalid.
Ethics declarations
Competing interests
This work was supported by The Alan Turing Institute via ‘Towards Turing 2.0’ EPSRC Grant Funding. Amgen, Astellas, Janssen, Synapse Management Partners and UCB Biopharma have funded or supported training programmes organised by SK’s department. SK receives funding support from Amgen BioPharma outside of this work. This research is part of the Data and Connectivity National Core Study, led by Health Data Research UK in partnership with the Office for National Statistics and funded by UK Research and Innovation (grant ref MC_PC_20058). The remaining authors have nothing to declare.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Gu, Q., Hasheminasab, S.A., Pineda-Moncusí, M. et al. Prevalence of 406 rare diseases by ethnicity and recorded COVID-19 infection rates among 62.5 million people in England. Sci Rep (2026). https://doi.org/10.1038/s41598-026-70531-4
Received: 19 January 2026
Accepted: 03 September 2026
Published: 18 October 2026
DOI: https://doi.org/10.1038/s41598-026-70531-4
Keywords
来源:Nature 健康护理主题 · nature.com